UBS has revised its price target for DocuSign (DOCU, Financial), reducing it from $90 to $85, following insights gathered during the company's recent user conference. Despite the adjustment in the price target, UBS continues to hold a Neutral rating on DocuSign shares.
The decision reflects UBS's current assessment of DocuSign's market position and future prospects. This revision indicates a slightly cautious approach towards the company’s near-term performance while maintaining a balanced outlook on its potential for growth.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 16 analysts, the average target price for Docusign Inc (DOCU, Financial) is $94.44 with a high estimate of $124.00 and a low estimate of $70.00. The average target implies an upside of 23.63% from the current price of $76.39. More detailed estimate data can be found on the Docusign Inc (DOCU) Forecast page.
Based on the consensus recommendation from 23 brokerage firms, Docusign Inc's (DOCU, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Docusign Inc (DOCU, Financial) in one year is $67.83, suggesting a downside of 11.21% from the current price of $76.39. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Docusign Inc (DOCU) Summary page.
